Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ceftazidime × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

pembrolizumab 525 Specimen Handling 486 Magnetic Resonance Spectroscopy 420 Carboplatin 339 Cyclophosphamide 322 Biopsy 292 Cisplatin 284 Paclitaxel 255 Nivolumab 239 Gemcitabine 223 Radiotherapy 211 Bevacizumab 187 Dexamethasone 186 fludarabine 181 venetoclax 174 Oxaliplatin 153 Docetaxel 152 Fluorouracil 148 atezolizumab 146 durvalumab 145 Rituximab 142 Pemetrexed 139 Capecitabine 136 Doxorubicin 128 Radiation 125 Lenalidomide 124 Standard of Care 119 Prednisone 116 Radiosurgery 115 Drug Therapy 114

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948463 2025-12-24

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡